Sinopharm Group Co. Ltd (X2S) - Total Liabilities

Latest as of June 2025: €291.07 Billion EUR ≈ $340.29 Billion USD

Based on the latest financial reports, Sinopharm Group Co. Ltd (X2S) has total liabilities worth €291.07 Billion EUR (≈ $340.29 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Sinopharm Group Co. Ltd (X2S) cash conversion ratio to assess how effectively this company generates cash.

Sinopharm Group Co. Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Sinopharm Group Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Sinopharm Group Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Sinopharm Group Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sinopharm Group Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Jumbo S.A. AT:BELA	Greece	€272.34 Million
Turkiye Sigorta AS IS:TURSG	Turkey	TL64.75 Billion
NBTM New Materials Group Co Ltd SHG:600114	China	CN¥3.84 Billion
Shufersal TA:SAE	Israel	ILA11.48 Billion
Catalyst Pharmaceuticals Inc NASDAQ:CPRX	USA	$152.54 Million
Wienerberger AG VI:WIE	Austria	€3.47 Billion
Shanghai Lingang Holdings Co Ltd A SHG:600848	China	CN¥52.22 Billion
Iskenderun Demir ve Celik AS IS:ISDMR	Turkey	TL79.07 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Sinopharm Group Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sinopharm Group Co. Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.63	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sinopharm Group Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sinopharm Group Co. Ltd (2013–2024)

The table below shows the annual total liabilities of Sinopharm Group Co. Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	€266.14 Billion ≈ $311.15 Billion	+1.17%
2023-12-31	€263.08 Billion ≈ $307.56 Billion	+3.29%
2022-12-31	€254.71 Billion ≈ $297.78 Billion	+8.04%
2021-12-31	€235.76 Billion ≈ $275.63 Billion	+6.54%
2020-12-31	€221.29 Billion ≈ $258.71 Billion	+14.69%
2019-12-31	€192.95 Billion ≈ $225.58 Billion	+15.20%
2018-12-31	€167.50 Billion ≈ $195.82 Billion	+41.62%
2017-12-31	€118.27 Billion ≈ $138.27 Billion	+4.50%
2016-12-31	€113.18 Billion ≈ $132.32 Billion	+14.84%
2015-12-31	€98.55 Billion ≈ $115.22 Billion	+6.70%
2014-12-31	€92.37 Billion ≈ $107.99 Billion	+20.20%
2013-12-31	€76.84 Billion ≈ $89.84 Billion	--

About Sinopharm Group Co. Ltd

F:X2S Germany Medical Distribution

Market Cap

$3.15 Billion

€2.69 Billion EUR

Market Cap Rank

#4790 Global

#801 in Germany

Share Price

€2.01

Change (1 day)

-0.94%

52-Week Range

€1.98 - €2.37

All Time High

€2.71